Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Net Margin (2020 - 2025)

Historic Net Margin for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 13.08%.

  • NeuroPace's Net Margin rose 138500.0% to 13.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.68%, marking a year-over-year increase of 129200.0%. This contributed to the annual value of 34.35% for FY2024, which is 155500.0% up from last year.
  • Per NeuroPace's latest filing, its Net Margin stood at 13.08% for Q3 2025, which was up 138500.0% from 34.72% recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Net Margin ranged from a high of 13.08% in Q3 2025 and a low of 123.58% during Q2 2022
  • For the 5-year period, NeuroPace's Net Margin averaged around 58.42%, with its median value being 50.5% (2021).
  • Per our database at Business Quant, NeuroPace's Net Margin plummeted by -730800bps in 2022 and then skyrocketed by 675800bps in 2023.
  • NeuroPace's Net Margin (Quarter) stood at 97.22% in 2021, then rose by 12bps to 86.01% in 2022, then soared by 58bps to 35.89% in 2023, then surged by 33bps to 24.06% in 2024, then surged by 46bps to 13.08% in 2025.
  • Its Net Margin was 13.08% in Q3 2025, compared to 34.72% in Q2 2025 and 28.89% in Q1 2025.